{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:20:05Z","timestamp":1792592405166,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.htct.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T21:37:50Z","timestamp":1626817070000},"page":"491-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia"],"prefix":"10.1016","volume":"44","author":[{"given":"Montserrat","family":"Rivera-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Carmina","family":"C\u00f3rdova-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto David","family":"El\u00edas-De-La-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Murrieta-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Aurelio","family":"Le\u00f3n-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0329-6487","authenticated-orcid":false,"given":"Yahveth","family":"Cantero-Fortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-3600","authenticated-orcid":false,"given":"Juan Carlos","family":"Olivares-Gazca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Jos\u00e9","family":"Ruiz-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-0653","authenticated-orcid":false,"given":"Guillermo Jos\u00e9","family":"Ruiz-Arg\u00fcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2021.06.004_bib0001","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.lfs.2012.11.004","article-title":"Nonalcoholic fatty liver disease: current and potential therapies","volume":"92","author":"Ibrahim","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.htct.2021.06.004_bib0002","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00535-012-0556-5","article-title":"Thrombocytopenia is more severe in patients with chronic hepatitis C than in patients with nonalcoholic fatty liver disease","volume":"47","author":"Mawatari","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.htct.2021.06.004_bib0003","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/SMJ.0b013e3181eb34ca","article-title":"Thrombocytopenia, NAFLD, and metabolic syndrome: is there a link?","volume":"103","author":"Dasanu","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.htct.2021.06.004_bib0004","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/SMJ.0b013e3181fa61ef","article-title":"Thrombocytopenia in NAFLD: is thrombopoietin involved?","volume":"103","author":"Dasanu","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.htct.2021.06.004_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000357934","article-title":"Nonalcoholic fatty liver disease may cause thrombocytopenia","volume":"132","author":"Ruiz-Arg\u00fcelles","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.htct.2021.06.004_bib0006","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/10245332.2016.1266435","article-title":"More on the thrombocytopenia of the non-alcoholic fatty liver disease","volume":"22","author":"Olivares-Gazca","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.htct.2021.06.004_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1076029619888694","article-title":"Nonalcoholic fatty liver disease and thrombocytopenia III: its association with insulin resistance","volume":"25","author":"L\u00f3pez-Trujillo","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.htct.2021.06.004_bib0008","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.aohep.2019.05.011","article-title":"Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease withouth cirrosis","volume":"19","author":"Panke","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.htct.2021.06.004_bib0009","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/14737159.7.5.481","article-title":"FibroMAX: towards a new universal biomarker of liver disease?","volume":"7","author":"Morra","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"10.1016\/j.htct.2021.06.004_bib0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/apt.12186","article-title":"Review Article: the diagnosis of non-alcoholic fatty liver disease","volume":"37","author":"Festi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.htct.2021.06.004_bib0011","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s10620-016-4079-4","article-title":"Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016","volume":"61","author":"Kaswala","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.htct.2021.06.004_bib0012","doi-asserted-by":"crossref","first-page":"11914","DOI":"10.3748\/wjg.v21.i42.11914","article-title":"Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(\u00ae))","volume":"21","author":"Lupsor-Platon","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.htct.2021.06.004_bib0013","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4254\/wjh.v5.i5.264","article-title":"Transient elastography: kill two birds with one stone","volume":"5","author":"Wong","year":"2013","journal-title":"World J Hepatol"},{"key":"10.1016\/j.htct.2021.06.004_bib0014","doi-asserted-by":"crossref","unstructured":"Cobb J, Gall W, Adam KP, et\u00a0al. A novel fasting blood test for insulin resistance and prediabetes. 2013;7:100\u201310.","DOI":"10.1177\/193229681300700112"},{"key":"10.1016\/j.htct.2021.06.004_bib0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921000985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921000985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:12Z","timestamp":1762868112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137921000985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2531137921000985"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2021.06.004","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}